ENO1 exhibited consistent prognostic implications in multiple tumor types, acting as a risk factor in cancers such as SARC, LUAD, LIHC, LAML, KICH, HNSC, CESC, BLCA, and ACC, whereas it showed a protective association in KIRC (Figure 10B). Here, ENO1 is linked to adrenal cortex carcinoma.